DTT
| Code | Size | Price |
|---|
| TAR-T5370-500mg | 500mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
DL-Dithiothreitol (DTT) is a reagent for maintaining SH groups in the reduced state.
CAS:
03/12/3483
Molecular Weight:
154.25
Purity:
0.98
SMILES:
O[C@@H](CS)[C@@H](O)CS.O[C@H](CS)[C@H](O)CS
References
Sears DW, et al. Relative susceptibilities of the interchain disulfides of an immunoglobulin G molecule to reduction by dithiothreitol. Biochemistry. 1977 May 3;16(9):2031-5.
Wang J K, Li Y, Zhao X L, et al. Ablation of Plasma Prekallikrein Decreases LDL Cholesterol by Stabilizing LDL Receptor and Protects Against Atherosclerosis. Circulation. 2022
Wang J K, Li Y, Zhao X L, et al. Ablation of Plasma Prekallikrein Decreases LDL Cholesterol by Stabilizing LDL Receptor and Protects against Atherosclerosis. Circulation. 2022;145:675?687